In the ongoing debate about tobacco policy one of the most contentious questions is whether cigars should be regulated in exactly the same way as cigarettes. Our position here is clear: while cigars and cigarettes share some harmful features, treating cigars identically to cigarettes in regulation would be misguided. The differences in usage patterns, product characteristics, market dynamics, and public-health implications all suggest that a one-size-fits-all regulatory approach is inappropriate.

First, it is important to acknowledge that cigars are not harmless. Research shows that cigar smoke contains many of the same toxic and carcinogenic constituents found in cigarette smoke and that heavy cigar use confers elevated disease risks. For example, a review of the science reports that cigar smoke “is as, or more, toxic and carcinogenic than cigarette smoke” though differences in disease risks hinge on usage intensity and inhalation patterns. (Cancer Control) Nonetheless, the mere presence of risk does not automatically mean that cigars should be regulated identically to cigarettes.

One of the key differences lies in usage pattern. Many large cigar smokers tend to use the product less frequently, often for special occasions, rather than daily consumption typical of many cigarette smokers. A study examining usage of premium cigars found that patterns of consumption differ significantly from cigarettes. (OUP Academic) Moreover, a systematic review of cigar, cigarillo, and little-cigar use concluded that the diversity of cigar types (large hand-rolled cigars, cigarillos, little cigars) has very different risk profiles and usage behaviors compared with cigarettes. (ScienceDirect) Thus, regulation calibrated for daily habitual cigarette use may not appropriately match the realities of cigar use.

Another important point is product and market differentiation. Cigarettes are highly standardized as a product: paper-wrapped, filtered, designed for inhalation, typically consumed many times per day. By contrast cigars come in a wide variety of sizes, wrapper materials, filler types, frequency of use, and cultural meanings. The “premium cigar” market often emphasizes craftsmanship, aging of tobacco, and occasional use, distinguishing itself from the mass-market cigarette model. (PMC) The fact that cigars are not currently regulated in the same way as cigarettes is in part reflective of that difference: the federal excise tax system, for instance, treats cigarettes and cigars very differently. The U.S. Government Accountability Office (GAO) noted that cigarettes and roll-your-own tobacco are regulated under the U.S. Food and Drug Administration (FDA) in a manner that cigars and pipe tobacco historically were not, with large tax disparities among the products. (Government Accountability Office) The fact of these differences suggests there is rationale for treating them differently shows that regulation should reflect the reality of the product, not simply assume equivalence.

From a public-policy standpoint, one might argue that if cigars carry similar risks they should be regulated identically to cigarettes. But this overlooks the principle of proportionality in regulatory design. If regulation is overly burdensome relative to risk, unintended consequences may follow. For example, overly heavy regulation might drive premium cigar enthusiasts underground or displace them into unregulated product categories, potentially reducing transparency and monitoring. Furthermore, not all cigars are used in the same way or present risk in the same way as cigarettes; a daily-inhalation pattern of smoking one pack of cigarettes is quite different from an occasional finely crafted cigar smoked for leisure. A regulatory regime that fails to acknowledge that difference risks overreach.

It is worth noting the effort to regulate cigars more strictly has already been under discussion. The FDA has proposed rules to remove menthol cigarettes and all flavored cigars from the market, recognizing that flavored cigars attract younger users. (Truth Initiative) But that same source notes that declines in cigar use among youth have not been as steep as for cigarettes, suggesting that cigars are operating by different dynamics in the marketplace. Therefore regulation that attaches to these particular risk dimensions (flavors, youth-oriented marketing, accessibility) may be more appropriate than full regulatory symmetry with cigarettes.

From a practical perspective, one can imagine regulatory tiers. For instance, large hand-rolled premium cigars primarily consumed by adults could face a lighter regulatory framework (e.g., age verification, taxation reflective of premium price, disclosure requirements) rather than the full suite of cigarette-style restrictions (plain packaging, flavor bans, heavy excise taxes, frequent pack size minimums). At the same time, cigarillos and little cigars, which may resemble cigarettes in size and frequency of use, might be regulated more stringently. In other words, rather than “one law fits all,” nuanced regulation tied to product type, consumption pattern, marketing, and risk makes more sense.

To treat cigars the same as cigarettes would also risk erasing the cultural and social contexts in which cigars are used. Many cigar smokers consciously choose cigars for different occasions, different consumption habits, and different experiences. While public-health goals must remain paramount, regulation that fails to respect those social distinctions may face backlash, reduced compliance, and unintended reduction in legitimate adult consumer choice.

A final consideration is resource allocation. Regulators and public-health agencies have limited capacity. If the regulatory apparatus treats everything the same, the focus may drift away from highest-risk behaviors. Cigarettes remain the tobacco product most widely used and causing the bulk of harm. A regulatory system that is calibrated properly can allow public-health resources to concentrate on major risks while still monitoring less-frequently used products appropriately.

In conclusion, cigars should not be regulated exactly like cigarettes. That does not mean no regulation – far from it. Rather regulation should be smart, nuanced, and proportionate to the product and usage patterns. The differences in product nature, consumer behavior, market dynamics, and risk profiles all argue for a regulatory regime that recognizes cigars’ distinct character. The public health objective remains unchanged: to reduce harm, prevent youth uptake, and protect communities. But regulatory strategy should reflect the diversity of tobacco products and avoid simply importing cigarette regulation wholesale into the cigar context. In doing so we can foster effective oversight without unintended negative consequences, protect adult choice, and ensure that limited regulatory resources are deployed where they will have the greatest impact.